Treatment of immune-mediated, dysimmune neuropathies (Q36189269)

12 August 2017

1 reference

title

Treatment of immune-mediated, dysimmune neuropathies (English)

1 reference

12 August 2017

Finsterer J

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

Acta Neurologica Scandinavica

12 August 2017

published in

1 reference

12 August 2017

volume

112

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

115-125

1 reference

Clinical spectrum of chronic acquired demyelinating polyneuropathies

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

Immune mediated neuropathies--an update on therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

Contribution of corticosteroid to the treatment of pain in the acute phase of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

Treatment of immune neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

Research criteria for defining patients with CIDP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

Distal acquired demyelinating symmetric neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

Improvement of a CIDP associated with hepatitis C virus infection using antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

The spectrum of chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

Cyclosporin A in treatment of refractory patients with chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

Mycophenolate in treatment-resistant inflammatory neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

Sustained remission of CIDP associated with Evans syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

How long is IVIg effective in multifocal motor neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

Therapy of CIDP and related immune-mediated neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

Clinical features, evaluation, and treatment of patients with polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

Intravenous immunoglobulin in autoimmune neuromuscular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

POEMS syndrome: definitions and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

Efficacy and safety of rituximab in type II mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00448.X

10.1111/J.1600-0404.2005.00448.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference